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Abstract
 
Differentiation of dendritic cells (DCs) into particular subsets may act to shape innate and adap-
tive immune responses, but little is known about how this occurs during infections. Plasmacy-
toid dendritic cells (PDCs) are major producers of interferon (IFN)-
 
 
 
/
 
 
 
 in response to many
viruses. Here, the functions of these and other splenic DC subsets are further analyzed after in
vivo infection with murine cytomegalovirus (MCMV). Viral challenge induced PDC matura-
tion, their production of high levels of innate cytokines, and their ability to activate natural
killer (NK) cells. The conditions also licensed PDCs to efficiently activate CD8 T cells in vitro.
Non-plasmacytoid DCs induced T lymphocyte activation in vitro. As MCMV preferentially
infected CD8
 
 
 
 
 
 DCs, however, restricted access to antigens may limit plasmacytoid and
CD11b
 
 
 
 DC contribution to CD8 T cell activation. IFN-
 
 
 
/
 
 
 
 regulated multiple DC re-
sponses, limiting viral replication in all DC and IL-12 production especially in the CD11b
 
 
 
subset but promoting PDC accumulation and CD8
 
 
 
 
 
 DC maturation. Thus, during defense
against a viral infection, PDCs appear specialized for initiation of innate, and as a result of their
production of IFN-
 
 
 
/
 
 
 
, regulate other DCs for induction of adaptive immunity. Therefore,
they may orchestrate the DC subsets to shape endogenous immune responses to viruses.
Key words: plasmacytoid dendritic cell • interferon 
 
 
 
/
 
 
 
 • murine cytomegalovirus • antigen 
presentation • CD8 T lymphocyte
 
Introduction
 
Dendritic cells (DCs),
 
*
 
 initially identified by their ability to
initiate adaptive immune responses through antigen-spe-
cific activation of naive T cells (1), are now known to be
also involved in innate immune responses through the se-
cretion of antimicrobial cytokines such as IFN-
 
 
 
/
 
 
 
 (2) or
activation of other cellular effectors such as NK cells (3).
They are heterogeneous populations. According to their
frequency, DCs isolated from spleens of untreated, specific
pathogen-free mice can be divided into three major subsets
(4, 5): Ly6G/C
 
 
 
CD8
 
 
 
 
 
CD11b
 
 
 
 (later referred to as
CD11b
 
 
 
 DCs), Ly6G/C
 
 
 
CD8
 
 
 
 
 
CD11b
 
 
 
 (CD8
 
 
 
 
 
DCs), and Ly6G/C
 
 
 
CD8
 
 
 
 
 
/
 
 
 
CD11b
 
 
 
 plasmacytoid DCs
(PDCs). The subsets can all be derived from a common
B220
 
 
 
Ly6G/C
 
 
 
CD8
 
 
 
 
 
CD11b
 
 
 
 precursor (6, 7), depend-
ing on the cytokine environment (5, 8), but different patterns
of cytokine production by DC subsets may occur in re-
sponse to particular microbes (4, 9) and function for anti-
gen presentation can be assigned to different DC subsets
depending on conditions of challenge (10–13). For exam-
ple, both CD8
 
 
 
 
 
 and CD11b
 
 
 
 DCs can be potent activa-
tors of naive T lymphocytes, but CD8
 
 
 
 
 
 DCs have a
unique ability to cross-present exogenous antigen in associ-
ation with MHC class I molecules (11–13). By contrast,
PDCs have been reported poor activators of CD4 T cells,
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even after stimulation in vitro (14–16). Thus, a picture is
emerging of specialization of DC subsets in recognition of,
and responses to, specific molecules expressed during mi-
crobial infections. In turn, the activation of these subsets
may lead to specific pathways for differential regulation of
downstream immune responses. However, knowledge on
the respective roles of DC subsets in the course of micro-
bial infections in vivo is scarce (9, 17–19), and extensive si-
multaneous analyses of the different functions of the major
DC subsets in a given system remain to be done.
We have reported that splenic DCs are maintained as
plasmacytoid, CD8
 
 
 
 
 
 and CD11b
 
 
 
 subsets, and demon-
strated the major contribution of PDCs to IFN-
 
 
 
/
 
 
 
and  IL-12 production, during murine cytomegalovirus
(MCMV) infection (9). However, the impact of in vivo vi-
ral infections on antigen presentation capability of PDCs
and the relative consequences of particular DC functions
on other DC subsets have not been evaluated previously.
There is a high potential for PDCs to orchestrate both in-
nate and acquired immune responses during certain viral
infections, because the IFN-
 
 
 
/
 
 
 
 cytokines produced by
the subset can mediate multiple immunoregulatory func-
tions (20). IFN-
 
 
 
/
 
 
 
 regulate innate cytokine production
during viral infections by promoting high levels of their
own (9, 21) but limiting IL-12 production (9, 22). They
also induce up-regulation of MHC class I molecules and
regulate DC maturation in culture or in response to CFA
or CpG in vivo (23–25).
The studies presented here were undertaken to examine
the functional specialization of plasmacytoid, CD8
 
 
 
 
 
 and
CD11b
 
 
 
 DC subsets, and their regulation by IFN-
 
 
 
/
 
 
 
functions, during MCMV infection in vivo. The following
questions were addressed. (a) What is the relative contribu-
tion of DC subsets to production of a panel of innate cy-
tokines involved in defense and to NK cell activation? (b)
Can PDCs activate naive T cells during viral infections? (c)
Is MCMV replication within DCs part of the activation for
cytokine production and/or antigen presentation? (d) Is
PDC IFN-
 
 
 
/
 
 
 
 production regulating DC responses during
microbial infections in vivo? To examine these issues, DC
subsets were isolated from the spleens of untreated or d1.5
MCMV-infected mice and analyzed for various parameters.
The time point was chosen as it is relevant to functions in-
volved in the activation of both innate and acquired immu-
nity; day 1.5 corresponds to the peak of innate cytokine
production (9, 26) and to the likely initiation of acquired
immune responses (27–29). Globally, PDCs and other DC
subsets mediated nonredundant, complementary functions.
Even though they had acquired the ability to efficiently ac-
tivate CD8 T cells in vitro, PDCs appeared specialized in
the initiation of innate immune responses in vivo, and
other DCs in the induction of T cell responses. However,
multiple DC functions were regulated by PDC-derived
IFN-
 
 
 
/
 
 
 
, in a specific way for each DC subset. Thus, the
results suggest a coordinated specialization of DC subsets in
the activation of different arms of the immune system with
PDCs and their responses orchestrating the events during a
viral infection in vivo.
 
Materials and Methods
 
Mice, Virus, and Treatments.
 
IFN-
 
 
 
/
 
 
 
 receptor-deficient
(IFN-
 
 
 
/
 
 
 
R
 
 
 
/
 
 
 
) 129 mice were bred under pathogen-free condi-
tions in the animal care facility at Brown University. Specific
pathogen-free wild-type 129 (129SvEv TacFBR) and C57BL/6
mice were purchased from Taconic Farms, as well as C57BL/6
RAG-2
 
 
 
/
 
 
 
 mice transgenic for a TCR specific for the lympho-
cytic choriomeningitis virus (LCMV) epitope GP-33–41 (H2-D
 
b
 
),
strain 4113-TcR P14 (30). Mice were 5 to 12 wk of age. Han-
dling of mice and experimental procedures were conducted in ac-
cordance with institutional guidelines for animal care and use. In-
fections were initiated on d0 by intraperitoneal injection of 10
 
4
 
PFU of salivary gland-extracted MCMV Smith strain, WT, or
clone RVG-102 (31) recombinant for the enhanced green fluores-
cence protein (GFP) under the promoter of the immediate early
gene-1 (ie-1). In certain experiments, NK cells were depleted in
vivo by intraperitoneal injection of anti-AGM1 antibody (Wako
Pure Chemical Industries, Ltd.) 1 d before and 12 h after infection.
 
Preparation of Cell Suspensions and Subset Enrichment.
 
Spleens
were digested by collagenase and cells suspensions prepared as de-
scribed (9). DCs and NK cells were enriched using anti-CD11c or
anti-DX5 magnetic beads and positive selection columns MS
 
 
 
 ac-
cording to manufacturer’s instructions (Miltenyi Biotec). Ly6G/
C
 
 
 
 versus Ly6G/C
 
 
 
, CD11b
 
 
 
 versus CD11b
 
 
 
, or GFP
 
 
 
 versus
GFP
 
 
 
, DC subsets were purified from enriched CD11c
 
 
 
 cells by
fluorescence-activated cell sorting using a FACSVantage™ with a
70-
 
 
 
m nozzle (9). Similarly NK cells were further purified as
DX5
 
 
 
CD3
 
 
 
 
 
 cells. Purity and viability of sorted populations
were analyzed immediately after sorting. CD8 T cells from P14
mice were prepared by negative selection using CD8 T cell en-
richment kits, supplemented with CD11c-microbeads to ensure
depletion of endogenous DC populations (Miltenyi Biotec).
 
Quantitation of Cytokines and Macrophage Inflammatory Protein 1
 
 
 
.
 
Supernatants from purified DC subsets or from cocultures of DCs
with NK or T cells were harvested and tested in ELISA. Com-
mercial kits were used for IL-12p40 and macrophage inflamma-
tory protein (MIP)-1
 
 
 
 (R&D Systems), as well as a custom anti-
body pair for IL-12p40 as described previously (26). Limits of
detection were 20 pg/ml for IL-12p40 and 
 
 
 
1.5 pg/ml for MIP-1
 
 
 
.
The IFN-
 
 
 
, IFN-
 
 
 
, IL-18, and TNF-
 
 
 
 ELISA have been de-
scribed previously (9, 32, 33). Limits of detection were 1,500 pg/
ml for IFN-
 
 
 
, 5 pg/ml for IFN-
 
 
 
, 30 pg/ml for IL-18, and 
 
 
 
5
pg/ml for TNF-
 
 
 
. Cytokine titers were expressed as pg/ml or
ng/ml for 10
 
6
 
 cells for analyses in overnight DC cultures and as
pg/ml or ng/ml for analyses in DC/NK or T cells cocultures.
 
Flow Cytometric and Immunofluorescence Analyses.
 
Cell surface
stainings were performed as described (9), using the following
antibodies: CD11c-FITC, CD11c-PE, CD8
 
 
 
-APC, CD11b-
FITC, CD11b-APC, Ly6G/C-FITC, Ly6G/C-APC, Ly6G/C-
PE/Cy5, I-A
 
b
 
-PE, H2-K
 
b
 
-PE, CD40-PE, CD80-PE, CD86-PE,
CD3
 
 
 
-FITC, NK1.1-PE, and DX5-biotin with streptavidin-PE,
purchased from BD Biosciences or eBioscience. Hyperimmune
serum from MCMV-infected mice was used as a primary anti-
body and Cy5-conjugated affinity-purified F(ab)
 
 
 
2
 
 fragment
donkey anti–mouse IgG (Jackson ImmunoResearch Laborato-
ries) as a secondary reagent for staining of viral membrane anti-
gens. Freshly isolated cells were evaluated ex vivo for intracellu-
lar expression of IL-12 and IFN-
 
 
 
 as described (9), and of
MCMV IE-1 protein using the Croma antibody (34) as a pri-
mary reagent and Cy5-conjugated donkey anti–mouse Ab as a
secondary reagent. Samples were acquired using a FACSCali-
bur™ (Becton Dickinson), with the CELLQuest™ version 3.1
software package. Laser outputs were 15 mW at 488 and 635 nmT
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wavelengths. For immunofluorescence studies of DC subset
morphology and MHC class II expression, DCs were stained
with CD11c-PE and Ly6G/C-FITC, purified by cell sorting in
total CD11c
 
 
 
 cells or in Ly6G/C
 
 
 
 and Ly6G/C
 
 
 
 subsets,
restained in suspension with biotin-I-A
 
b
 
 followed by Texas
Red-streptavidin and Ly6G/C-FITC. Specificity was assessed on
total CD11c
 
 
 
 DCs using isotype control antibodies. Wright and
Giemsa stainings were performed in parallel to ensure the lack of
granulocyte contamination (unpublished data). Cytospins were
done at various cell inputs. Sorted GFP
 
 
 
 and GFP
 
 
 
 DCs isolated
from d1.5 RVG102-infected 129 mice were also examined by
immunofluorescence for intracellular localization of GFP. Slides
were dried, fixed with 1% paraformaldehyde, washed, and
mounted with anti-fading medium Vectashield (Vector Labora-
tories). Images were collected digitally with a single filter cube
with a Spot, RT slider camera from Diagnostics, Inc. (MVI), and
processed for publication with AdobePhotoshop.
 
RT-PCR for IL-15 mRNA.
 
Total RNA was extracted from
 
 5   106 cells and retro-transcribed as described previously (9). 5
 l c-DNA was used as a template for PCR amplification using
primers specific for IL-15 (35) synthesized by Operon. Amplifica-
tions were performed in a programmable thermal cycler (PTC-200;
MJ Research) with 30 cycles and an annealing temperature of 54 C.
Real-time RT-PCR for Quantification of MCMV mRNA. To-
tal RNA was isolated using RNeasy (QIAGEN). To minimize
contamination by viral genomic DNA, RNA was digested with
DNase (RNase-Free DNase Set; QIAGEN). Spin columns (Zy-
mogen) were used to concentrate samples. 100 ng total RNA was
used for reverse transcription of three RVG102 mRNAs - GFP,
the ie-1, and the MCMV late gene glycoprotein B (gB) - using
gene-specific oligonucleotide primers and a commercially avail-
able kit (Omniscript; QIAGEN). Mock reactions omitting re-
verse transcriptase were run as negative controls. Quantification
of cDNA was performed using a Light Cycler real-time PCR in-
strument (Roche Diagnostics) running Light Cycler software
v3.5.3. Hybridization probe sets were designed using TM Utility
v1.3, a freeware program from IT Biochem, and conjugated to
dyes such as to produce a fluorescent signal upon hybridization to
the accumulating PCR product (36). Hybridization of probes
was detected with the Roche Fast Start Master DNA Hybridiza-
tion Probes kit. 10% of the cDNA was used in the PCR reaction
as template for mRNA quantification. Standards consisted of 10-
fold dilutions of known concentrations of RVG102 genomic
DNA (104 copies–10 copies). Fluorescence was recorded at the
end of each annealing step. A single reaction consisted of 0.5  M
downstream primer, 1.0  M upstream primer, 0.2  M 3 FITC
probe, 0.4  M 5 LC Red 640 probe, 3 mM MgCl2, the kit mas-
ter mixes at 1  concentration, and cDNA template in a total
volume of 20  l. Oligonucleotide primers and fluorochrome-
labeled oligonucleotide probes were obtained from IT Biochem.
The sequences as well as cycling parameters used in the reactions
are given in Table I.
NK Cell Activation Assay. DC subsets were sorted from un-
infected or d1.5 MCMV-infected 129 mice. 5   104 DCs were
plated in coculture with 5   104 NK cells purified from the
spleen of uninfected 129 mice. After 24 h, 100  l of supernatant
was harvested from each well for IFN-  titration and replaced by
5   103 YAC cells labeled with 51Cr (PerkinElmer). In parallel,
NK cells were sorted from uninfected or d1.5 MCMV-infected
129 mice, plated at 5   104/well, and used directly ex vivo for
analysis of cytotoxic activity, or incubated for 24 h to measure
spontaneous IFN-  production. Wells with YAC cells alone
were plated for evaluation of spontaneous and total releases. The
chromium release assay was incubated for 6 h at 37 C, 5% CO2.
Supernatant (50  l) were transferred to a Lumaplate™, counted
using the Topcount instrument (Packard Instrument Co./Per-
kinElmer), and the percentage specific release was calculated as
described (37).
CD8 T Cell Antigen-specific Activation Assays. DC subsets
were sorted from uninfected or d1.5 MCMV-infected 129 mice,
pulsed for 3 h at 37 C, 5% CO2 in a solution of the LCMV pep-
tide GP33–41 (H-2Db), or with the LCMV peptide NP 396–
404 (H-2Db) as a negative control. Unless specified, peptides
were used at 10  M. DCs were washed three times and resus-
pended in fresh medium. 5   104 viable naive GP33–41-specific
CD8 T cells purified from the spleens of P14 mice were plated
in each well with serial dilutions of the various DC suspensions.
After 2 d of culture, 100  l of supernatant was harvested from
each well for IFN-  titration, and cells were pulsed with 1  Ci
of 3H-thymidine (PerkinElmer) in 100  l of fresh medium for
Table I. Oligonucleotides and Cycling Parameters Used for Real-time RT PCR on MCMV Genes
Gene Primersa Probes Cyclesb
GFP 5 TGCCGTCCTCGATGTTGTGG3  5 LCRed640GCCACAACGTCTATATCATGGCCGACA3  95 C 15 s
5 AGCACGACTTCTTCAAGTCC3  5 CCTGGGGCACAAGCTGGAGTACAACTACAAFITC3  63 C 15 s
5 CCTTGATGCCGTTCTTCTGC3  72 C 15 s
ie-1 5 TATCATGAGGTGTGCAATCT3  5 LCRed640GGCCATCAAGCATGCTGCCAGGT3  95 C 10 s
5 TACAGGACAACAGAACGCTC3  5 CCACGTGGGGAATGATAACAGCGACAFITC3  60 C 15 s
5 CCTCGAGTCTGGAACCGAAA3  72 C 10 s
gB 5 GTAGTCCCGATACTCGTAGC3  5 LCRed640GGAACCTTTCGGACGGAGAACTGTGAC3  95 C 10 s
5 AAGGACTACATCAACGATGCG3  5 AGCTGGGCGAAAACAACGAGATTATGCTFITC3  65 C 15 s
5 CACGACGAAGATCTTCCTGC3  72 C 10 s
aThe first sequence corresponds to the primer used in the reverse transcription, the two other sequences to the primers used in the real-time PCR. 
bPolymerase was first activated by heating for 10 min at 95 C. T
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the last 18 h. Cells were collected and counted using the Packard
Filtermate Universal Harvester and Topcount instruments
(Packard Instrument Co.).
IFN-  ELISPOT Assays. The IFN-  ELISPOT assays were
adapted from IFN-  ELISPOT described previously (38). In
brief, Multiscreen–IP plates (Millipore) were coated overnight
with 0.5  g/well of the same primary antibody as used for the
ELISA, washed, and blocked for 3 h with culture medium. Serial
dilutions of enriched DCs from uninfected or d1.5 MCMV-
infected 129 mice were then plated and incubated overnight at
37 C, 5% C02. Plates were washed and incubated with the same
secondary antibody as in the ELISA, followed by biotinylated
anti–rabbit antibody with minimal cross-reactivites between spe-
cies (Jackson ImmunoResearch Laboratories) and extravidin-
phosphatase alkaline (Sigma-Aldrich). Spots were developed and
counted as described (38).
Statistical Analyses. Statistical analyses were performed in Mi-
crosoft Excel 5.0 (Microsoft Corporation, Redmond, WA) using
student’s two-tailed t tests. Unless otherwise indicated, means  
SE are shown.
Figure 1. Morphology and MHC class II expression by DC subsets. DCs were purified from d1.5 MCMV-infected 129 mice and stained for FITC-
Ly6G/C and Texas-Red MHC class II (I-Ab). Cytospins were analyzed by fluorescent microcopy using a double red/green filter. Representative photo-
graphs of individual cells are shown. Scale bar is 10  m. (A–C) CD11c Ly6G/C  purified cells. Most cells show a round morphology (A and B) and do
not express detectable levels of MHC class II. Only few cells have dendrites (C). (D–F) CD11c Ly6G/C  purified cells. All cells express high levels of
MHC class II and most of them have a clear web of long dendrites (E and F). (G) One example of the few cells coexpressing Ly6G/C and MHC class II.
(H and I) Photographs taken from total CD11c  purified cells showing Ly6G/C  MHC class II  plasmacytoid cells and Ly6G/C  MHC class II  cells
with developed dendrites in a single magnification field.T
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Results
Innate Cytokine/Chemokine Production and NK Cell Activa-
tion by DC Subsets. The major producers of IFN- / 
and IL-12 during MCMV infections are CD11cdullLy6G/
C CD8  / CD11b  cells (9). To further characterize
these cells, CD11c  populations were isolated from
spleens of d1.5 MCMV-infected mice, stained for cell
surface markers, and examined microscopically. The
CD11cdullLy6G/C CD8  / CD11b  cells had plasmacy-
toid morphology and low expression of MHC class II as
compared with CD11chighLy6G/C  DCs (Fig. 1). Experi-
ments were performed to determine if PDCs were induced
to express other innate cytokines during MCMV infection.
TNF- , MIP-1 , IFN- , IL-15, and IL-18 were evalu-
ated because these molecules also play critical roles early in
the control of virus infection (32, 39, 40). In addition to
IFN- /  and IL-12, PDCs isolated from d1.5 MCMV-
infected mice produced higher levels of TNF-  and MIP-1 
than the other DC subsets (Fig. 2 A). They did not pro-
duce IFN- , which mostly originated from NK cells (Fig.
2 B) as reported previously (41). IL-15 mRNA expression
was induced in total splenic leukocytes after MCMV infec-
tion. However, it segregated with non-DC populations
upon sorting (Fig. 2 C). Similarly, IL-18 protein was in-
duced in non-DC populations (unpublished data). Thus,
PDCs are specialized in the production of a specific array
of innate cytokines/chemokines in vivo during MCMV
Figure 2. Innate cytokine/chemokine
production and NK cell activation by DC
subsets. Mice were untreated or infected in-
traperitoneally for 1.5 d with 104 PFU
MCMV. The ability of DC subsets to pro-
duce various soluble factors ex vivo and to
rapidly activate NK cells in vitro was then
evaluated. (A) Cytokine and MIP-1  titers
in 24 h conditioned media from Ly6G/C 
(left) and Ly6G/C  (right) DC subsets iso-
lated from the spleens of d1.5 MCMV-
infected 129 mice. The top dot-plots show
the populations after sorting. The purity was
typically  95% for Ly6G/C  and  99% for
Ly6G/C  DCs. No or very low levels of cy-
tokines were detected in DCs isolated from
uninfected mice (unpublished data). The
data are representative of at least three inde-
pendent experiments. Similar results were
obtained with DC subsets enriched from
mice depleted of NK cells in vivo (unpub-
lished data). (B) Flow cytometry analyses of
IL-12 and IFN-  expression ex vivo in
Ly6G/C  DCs (top panels) and in NK cells
(bottom panels) from d1.5 MCMV-infected
C57BL/6 mice. Similar results were ob-
tained with cells from 129 mice, although
with a lower production of IFN-  (unpub-
lished data). (C) Analyses of the expression of
IL-15 mRNA by splenic leukocytes freshly
isolated from d1.5 MCMV-infected or vehi-
cle-treated 129 mice and fractionated for
CD11c expression. IFN- /  mRNA were
detectable in all samples from infected mice
(reference 9). (D) NK cell activation by DC
subsets. Splenic NK cells were sorted from
untreated 129 mice and cocultured for 24 h
with Ly6G/C  or Ly6G/C  DCs isolated
from the spleen of untreated (d0) or d1.5
MCMV-infected 129 mice. As a positive
control, NK cells were isolated from d1.5
MCMV-infected mice and tested directly ex
vivo (gray bars). Cytotoxic activity against
YAC cells (top panel) and IFN-  production
(bottom panel) were then evaluated as de-
scribed in Materials and Methods. Cytotoxic
responses in cocultures are shown after sub-
traction of the background measured in cul-
tures of DCs or NK alone. No IFN-  pro-
duction was observed in cultures of DCs
alone or NK cells isolated from uninfected
mice alone. BLD, below level of detection.T
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infection, and appear much more potent for this function
than other DCs.
The ability of DC subsets to rapidly activate NK cells in
vitro was assessed. Ly6G/C  and Ly6G/C  DCs were iso-
lated from uninfected or d1.5 MCMV-infected mice and
cocultivated with NK cells freshly isolated from uninfected
mice. After 24 h, parameters of NK cell activation were
measured (Fig. 2 D). Low levels of cytotoxicity were de-
tectable in cultures of DCs alone from infected mice, even
after in vivo depletion of NK cells (unpublished data).
However, a clear induction of cytotoxic activity and IFN- 
production was detectable after coculture of NK cells with
PDCs from infected mice, but not with PDCs from unin-
fected mice or with Ly6G/C  DCs. The levels of IFN- 
production and cytotoxic activity induced upon in vitro ac-
tivation were within two- to fourfold of those of NK cells
isolated at the peak time of in vivo activation, i.e., d1.5 after
infection. No NK cell proliferation was detected in any of
the conditions tested (unpublished data). Thus, in response
to MCMV infection in vivo, PDCs specifically appear to
acquire a potential for rapid activation of NK cell functions.
Antigen Presentation Potential. The maturation status and
antigen presentation potential of PDCs were compared
with those of other DCs (Fig. 3). Immature PDCs ex-
pressed far lower levels of MHC class II and costimulatory
molecules than other DC subsets (Fig. 3 A). By contrast,
their level of MHC class I expression was similar. After in
vivo infection with MCMV, all DC subsets up-regulated
MHC and costimulatory molecules. However, the expres-
sion of MHC class II and costimulatory molecules re-
mained globally less on PDCs. Thus, PDCs mature in vivo
in response to MCMV infection but may retain a lower
potential for T cell priming than other DC subset.
The ability of DCs to activate CD8 T cells was evaluated
next. As both CD8   and CD11b  DCs are known to
have a high potential for antigen-specific priming of T
lymphocytes in vitro when pulsed with peptides, these two
subsets were analyzed together (i.e., Ly6G/C  DCs) for in-
duction of CD8 T cell responses in vitro. Freshly isolated
CD8 T cells expressing a transgenic TCR specific for the
LCMV epitope GP-33–41 were cocultured with peptide-
pulsed DC subsets (Fig. 3 B). Immature PDCs were far less
efficient than their Ly6G/C- counterparts at priming CD8
T cells, both in terms of proliferation and IFN-  produc-
tion. However, after in vivo challenge with MCMV,
PDCs became as potent as other DCs for antigen-specific
activation of naive CD8 T cells, and induced higher levels
of IFN- . The responses occurred only in the presence of
an antigen-specific activation of the CD8 T cells, as they
were not observed when DCs were pulsed with a negative
control peptide (data not depicted). Peptide concentrations
required to induce efficient activation of CD8 T cells by
nonplasmacytoid DCs and mature PDCs were similar, with
responses reaching a plateau at 1 nM (Fig. 3 C). Thus, im-
mature PDCs are not very efficient at priming T cells.
However, PDCs become very potent antigen-presenting
cells for CD8 T lymphocytes in vivo in response to
MCMV infection.
To evaluate the potential role of DC subsets for in vivo
activation of antiviral CD8 T cells, their accessibility to vi-
ral antigens for presentation with MHC class I was evalu-
ated during MCMV infection. To accomplish this, a re-
combinant virus RVG-102 expressing GFP under the ie-1
promoter (31) was used to track the DCs replicating
Figure 3. DC subset maturation and activation of T cells. (A) Expression
of MHC and costimulatory molecules on DC subsets from uninfected
(dotted line) and d1.5 MCMV-infected (bold line) 129 mice. Splenic
DCs were enriched using CD11c microbeads and the expression of MHC
class II I-Ab, class I H-2Kb, CD80, CD86, and CD40 molecules (x-axis)
was analyzed on DC subsets (y-axis). Stainings with isotype control anti-
bodies are shown as gray histograms. The data shown are representative of
at least three independent experiments. (B) In vitro antigen-specific acti-
vation of CD8 T cells by DC subsets. Ly6G/C  ( ,  ) and Ly6G/C 
( ,  ) DC subsets were sorted from uninfected ( ,  ) or d1.5 MCMV-
infected ( ,  ) 129 mice, pulsed with the LCMV GP33–41 epitope, and
cocultivated for 2 d with naive CD8 T cell expressing a transgenic TCR
specific for this peptide. Proliferation (left panel) and IFN-  production
(right panel) were measured after 2 d. DCs pulsed with the LCMV
NP396–404 epitope were used as a negative control, no activation of the
CD8 T cells was detectable in the corresponding cultures (unpublished
data). The data shown are representative of at least three independent ex-
periments. (C) Peptide dose–response curve for the analysis of DC subset
activation of CD8 T cells. Experiments were performed as above, except
that DCs were incubated with serial dilutions of the GP33–41 peptide
and plated at 10,000 cells/well. The data are representative of three inde-
pendent experiments.T
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MCMV or taking up apoptotic bodies from infected cells
in vivo. A small proportion of DCs was clearly positive for
GFP at d1.5 after infection (Fig. 4 A, top left dot plot).
Flow cytometric analyses, using serum of hyper-immune
mice for detecting overall membrane antigens, or the
Croma antibody for specifically detecting the IE-1 protein,
showed that most of the GFP  DCs had high intensity ex-
pression of the MCMV antigens, whereas no specific stain-
ing was observed on GFP  DCs (unpublished data). To
test for cells that might have been GFP  at the time of iso-
lation because they were at very early stages of viral repli-
cation, sorted GFP  DCs (Fig. 4 A, bottom left dot plot)
were reanalyzed for GFP expression after 24 h (bottom
right dot plot) or 48 h (unpublished data) in culture. As
compared with an initial fraction of 0.8–1% of GFP  cells
in total DCs, less than 0.03% of the negative DCs acquired
GFP expression over a 48 h period of culture. Thus, at the
time of ex vivo analysis, the populations at stages of pro-
ductive virus replication preceding detectable GFP expres-
sion represented less than 4% of total infected DCs. The
sensitivity of following GFP expression as an indication of
infection was further demonstrated by ex vivo analysis of
MCMV transcripts expression in total, GFP  and GFP 
DCs. These studies showed that most cells replicating
MCMV score as GFP  (Fig. 4 A, histograms) because
GFP  cells were highly enriched for mRNA expression of
the ie-1 and gB MCMV genes as quantified by the sensi-
tive real time RT-PCR analyses. Taken together, these re-
sults showed that analysis of GFP expression is a very sensi-
tive assay for detecting infected cells in our system.
Interestingly, most of the GFP  cells appeared to be repli-
cating the virus rather than taking up apoptotic bodies be-
cause 86% of the DCs expressed GFP throughout the cell
as evaluated by fluorescent microscopy (Fig. 4 B, a–c). A
punctuated pattern of expression was observed in only 14%
of the cells (Fig. 4 B, d and e). Characterization of the DC
subsets demonstrated that most of the GFP  cells belonged
to the CD8   population, whereas the number of GFP 
PDCs was very low (Fig. 4 C). Hence, although mature
PDC can efficiently prime naive CD8 T cells in vitro, their
contribution for this function during MCMV infection in
vivo may be low as compared with CD8   DCs, due to a
restricted access to viral antigen for presentation with
MHC class I molecules.
Role of Viral Infection and IFN- /  on DC Subset Cytokine
Production. Until recently, IFN- /  production during
viral infection was believed to occur mainly in infected
cells through triggering of intracellular receptors by viral
Figure 4. DC subset accessi-
bility to MCMV antigens in
vivo. (A) Analysis of the expres-
sion of MCMV transcripts in to-
tal, GFP  and GFP  DCs. DCs
were enriched from the spleen of
129 mice at 1.5 d after infection
with the MCMV clone RVG-
102, which express the GFP un-
der the ie-1 promoter. DCs were
then sorted in total, GFP  and
GFP  populations. The nega-
tive fraction was reanalyzed for
GFP expression after 24 h in
vitro culture, to allow expression
of the marker in the eventual
cells that were at very early stages
of viral replication and scored
negative at the time of isolation
(bottom right dot plot). Number
of events analyzed were 20,000
for total, 2,000 for GFP ,
770,000 for GFP , and 650,000
for GFP  24 h DCs. Percentages
of GFP  DCs are given above
each dot plot. The data are from
one representative experiment
out of three. RNA was extracted
from the GFP , total and GFP 
DC populations ex vivo, and
transcripts for GFP, ie-1, and the
glycoprotein-B (gB) were quan-
tified by real-time RT-PCR (bar graphs). For the gB transcripts, values were 1,258, 57 and undetectable for triplicates cell pellets of GFP  DCs. The data
are from one representative experiment of two. (B) Immunofluorescence analysis of GFP localization within positive DCs. Sorted GFP  DCs were ob-
served under a fluorescent microscope. No green signal was observed in the GFP  DCs under the same conditions (unpublished data). Scale bar is 10
 m. (C) Analysis of GFP expression in DC subsets. DCs were enriched from the spleen of 129 mice at 1.5 d after infection with RVG-102. The simul-
taneous expression of GFP (x-axis) and typical membrane markers (y-axis) was analyzed by flow cytometry within CD11c  cells (left panel) or
CD11c Ly6G/C  cells (middle and right panels). The percentages of cells in the quadrants are given above each dot-plot. The data are representative of
at least three independent experiments.T
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components (42). However, it has been recently shown
that IFN- /  can also be induced in vitro in uninfected
DCs through activation by glycosylated viral proteins (43)
or double-stranded RNA (44). During ongoing viral infec-
tions in vivo, it is not known whether cytokine production
is induced in single DCs as a result of viral replication in-
side the cell, of uptake of apoptotic bodies from dying in-
fected cells, or of other signals delivered by neighboring
infected cells. To address the relationship between expression
of viral products and production of IFN- / , the frequen-
cies of IFN-  spot-forming cells (SFCs) and of GFP  cells
were measured within DCs isolated from RVG-102–
infected mice, by ELISPOT and flow cytometry, respectively
(Fig. 5 A). After infection, the proportion of PDCs secret-
ing IFN-  was consistently higher than those expressing
GFP. These results were confirmed, and extended to IL-12
production, by comparing the levels of cytokines secreted
by sorted GFP  versus GFP  DCs (unpublished data).
Moreover, when GFP and IL-12 expression were analyzed
simultaneously in DC subsets isolated from d1.5 MCMV-
infected mice, by flow cytometry, it was demonstrated that
the two occurred in largely distinct populations of cells
(Fig. 5 B). This suggests that, at the single cell level, viral
replication or uptake of apoptotic bodies from infected cells
is neither required nor sufficient for induction of either
IFN- /  or IL-12 production in DCs.
Mice lacking IFN- /  functions produce more IL-12,
especially in CD11b  DCs, and this is associated with en-
hanced viral replication in the spleen (9). To determine
whether the increase in IL-12 production by CD11b  DCs
was a result of enhanced exposure to viral products in those
cells, we analyzed the relationship between GFP expression
and IL-12 production in DC from RVG-102–infected
IFN- / R /  mice. In the absence of IFN- /  functions,
a significant increase in GFP expression was observed in all
DC subsets (Fig. 5 C, Table II). An increase in the relative
Figure 5. Cytokine produc-
tion and expression of MCMV
products in DC subsets. (A)
Comparison of the frequencies
of cells secreting IFN-  or ex-
pressing viral products in PDCs.
The left panel shows photo-
graphs of IFN-  ELISPOT assays
performed with DC populations
from splenic leukocytes of 129
mice uninfected (d0) or at 1.5 d
after infection with the MCMV
clone RVG-102 (d1.5). The fre-
quencies of IFN-  spot forming
cells (SFC) versus GFP  cells
within PDCs are given on the
right (average and standard devi-
ations for three mice). (B) Simul-
taneous analysis of GFP (x-axis)
and IL-12 (y-axis) expression in
DC populations from splenic
leukocytes of 129 IFN- / R / 
at 1.5 d after infection with the
MCMV clone RVG-102. The
data are representative of at least
three independent experiments.
(C) Similar panel for IFN- /
 R /  mice. The data are repre-
sentative of two independent
experiments. (D) Impact of IFN-
 /  functions on DC subset ac-
cumulation in the spleen. IFN-
 / R /  (  ,   ,   ) versus
IFN- / R /  ( ,  ,  ) mice
were infected with MCMV for
various length of times and the
frequency of subsets (Ly6G/C :
 ,   , CD8  :   ,   , and
CD11b :  ,  ) in splenic DCs
was analyzed by flow cytometry.
The data shown are representative
of at least three independent ex-
periments for the 36 h time point.T
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contribution of the CD11b  DC subset to MCMV replica-
tion was consistently observed in the IFN- / R /  mice
at d1.5 and d2 after infection, where they accounted for
50% or more of the total GFP  DCs versus less than 30%
in the IFN- / R /  mice. However, in the absence of
IFN- /  functions, IL-12 production and GFP expression
still occurred in largely distinct populations of cells (Fig. 5
C, Table II). Moreover, a significant increase in IL-12 pro-
duction was observed in uninfected DCs, mostly in the
CD11b  subset but not in PDCs (Table II). These observa-
tions confirm that IFN- /  inhibits IL-12 production
preferentially in the CD11b  DC subset, and show that this
occurs in part independently of changes in expression of vi-
ral products within the cells.
We had previously reported that mice lacking IFN- / 
functions produced less of these cytokines (9). Here, the
impact of IFN- /  functions on the kinetics of DC subset
accumulation in the spleen during MCMV infection was
examined (Fig. 5 D). In contrast to other DC subsets, PDCs
frequency increased within the DC population of the spleen
to reach a peak around 36 h after MCMV challenge, at the
time of maximal IFN- /  production, in IFN- / R / 
mice. This increase was completely abrogated in IFN- /
 R /  mice. Thus, IFN- /  functions are necessary for
the accumulation of PDCs, the major IFN- /  producers,
in the spleen during MCMV infection, and this likely con-
tributes to the amplification of the cytokines.
Role of IFN- /  on Maturation of DC Subsets. The ex
vivo expression of MHC and costimulatory molecules by
DC subsets was next compared between IFN- / R / 
and IFN- / R /  mice at d1.5 MCMV infection (Fig. 6
A). No major changes were observed for MHC class II ex-
pression in the absence of IFN- /  functions. However,
the up-regulation of MHC class I and CD86 was reduced
on all DC subsets, but to different extents. The maturation
of the CD8   DC subpopulation was especially dependent
upon intact IFN- /  responses, as the up-regulation of
MHC class I, CD80, and CD86 was almost completely ab-
rogated, and that of CD40 reduced. In contrast, the matu-
ration of the CD11b  DCs was much less affected. Finally,
the injection of biologically active recombinant IFN-  in
the absence of viral infection did not induce detectable
maturation of the DCs (unpublished data). The differential
regulation of DC subset maturation by IFN- /  was con-
firmed at the functional level, as twice as many CD11b 
DCs were required to induce equivalent levels of CD8 T
cell antigen-specific proliferation in IFN- / R /  mice as
compared with their IFN- / R /  counterparts (Fig. 6
B). The levels of IFN-  secreted by the CD8 T cells were
also decreased when using CD11b  DCs from IFN- /
 R /  mice as antigen-presenting cells. Thus, even during
a viral infection where there is ongoing replication of a
pathogen and production of a complex array of innate cy-
tokines, intact IFN- /  functions are required to promote
the maturation of DCs, especially of the CD8   subset.
Discussion
We have established the critical contribution of mouse
PDCs to IFN- /  production during MCMV infection
(9). Here the functions and regulation of the three major
splenic DC subsets (i.e., PDCs, CD8  , and CD11b ) are
further characterized at d1.5 after MCMV infection. PDCs
from MCMV-infected mice secreted high levels of innate
cytokines and induced rapid activation of NK cells ex vivo.
PDCs from untreated mice had only weak antigen presen-
tation capabilities. MCMV infection in vivo induced PDC
maturation, licensing them to efficiently activate CD8 T
cells in vitro. Non-plasmacytoid DCs did not produce
IFN- / , secreted only low levels of the other innate cy-
tokines, and did not induce detectable NK cell activation
upon short coculture. However, they were very efficient at
activating naive CD8 T cells in vitro. Expression of
MCMV antigens seemed largely restricted to CD8  
DCs, suggesting that the contribution of other DC subsets
for in vivo activation of antiviral CD8 T cells may be low.
Thus, PDCs were specialized in the activation of innate
immune responses early during MCMV infection, whereas
other DCs were likely to initiate acquired immune re-
sponses. However, PDC-derived IFN- /  regulated mul-
tiple DC functions during MCMV infection in vivo, with
different effects on DC subsets. In particular, the cytokines
were necessary for maturation of CD8   DCs. Altogether,
the results suggest that PDCs are a cornerstone for induc-
tion of both innate and adaptive immune responses to
MCMV infection in vivo, through production of various
cytokines, direct activation of NK cells, and indirect regu-
Table II. Impact of IFN- /  Functions on MCMV Infection of, 
and IL-12 Production by, DC Subsets 
Percent GFP versus IL-12 expression in DC subsets
Mouse strain
DC subseta Population
IFN- / R / 
(n   3)c
IFN- / R / 
(n   4)c Pb
Ly6G/C CD8  /  GFP IL-12  0.26   0.04 3.38   0.40  10 4
GFP IL-12  0.25   0.05 5.16   0.45  10 5
GFP IL-12  7.15   1.81 7.95   0.61 NS
Ly6G/C CD8   GFP IL-12  2.63   0.89 11.54   0.83  10 4
GFP IL-12  1.30   0.26 8.17   1.21  10 3
GFP IL-12  2.63   0.53 4.50   0.09  10 2
Ly6G/C CD11b  GFP IL-12  0.29   0.09 2.42   0.23  10 3
GFP IL-12  0.08   0.03 1.31   0.23  10 3
GFP IL-12  0.79   0.12 1.95   0.21  10 3
a129 IFN- / R /  and IFN- / R /  mice were infected for 1.5 d
with MCMV RVG102 which encodes GFP under the promoter of the
ie-1 gene. DCs were enriched from spleens and stained for membrane
markers and intracellular IL-12 as described in Materials and Methods. 
bStatistical significance.
cMean   standard deviation. T
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lation of T cell functions by IFN- / –mediated effects on
other DCs.
Different mechanisms are in place to induce cytokine
production by cells from the innate immune system in re-
sponse to microbial challenges. Cells can produce cyto-
kines as a consequence of recognition of molecular patterns
shared within a class of microbes, through pattern-recogni-
tion receptors (PRRs; reference 45). Alternatively, re-
sponses can be triggered by host products generated during
inflammation, such as heat shock proteins (hsp; reference
46). Both cytoplasmic and membrane-bound PRRs have
been involved in IFN- /  induction during in vitro viral
challenges (42–44). All these mechanisms of danger recog-
nition are relevant to DC physiology, because DCs are sus-
ceptible to infection by many viruses, can engulf apoptotic
bodies from dying cells, and express a variety of mem-
brane-bound PRRs or hsp ligands. Here, the relationship
between expression of viral products and production of cy-
tokines in DC subsets was examined during MCMV infec-
tion. A virus recombinant for the GFP under the ie-1 pro-
moter was used to track DCs that were productively
infected by MCMV in vivo or had engulfed whole apop-
totic bodies from neighboring infected cells. GFP and cy-
tokine expression occurred in largely distinct populations
of DCs. As the results show that uptake of apoptotic bodies
from infected cells or productive viral infection within
DCs was neither required nor sufficient for induction of
cytokine production, some of the other pathways must
contribute to the induction of cytokine production by
DCs during MCMV infection. These likely include recog-
nition of viral components through Toll-like receptors
(TLRs; reference 45) or other receptors. Although beyond
the scope of this report, ongoing studies in our laboratory
are aimed at defining these.
Several investigators have shown the occurrence of an
auto-amplification pathway regulating the transcription of
interferon genes during viral infections in vitro (47). Our
group has demonstrated that intact IFN- /  functions
were required for high level productions of IFN- /  dur-
ing LCMV (21) and MCMV infections in vivo (9). As
IFN- /  have been shown to promote the survival of
PDCs in vitro both in the mouse (16) and in the human
(48), other mechanisms in addition to transcriptional regu-
lation of the interferon genes could be involved in the pos-
Figure 6. Impact of IFN- /  functions on DC subset
maturation. (A) Expression of MHC and costimulatory
molecules on DC subsets from untreated (dotted line) or
d1.5 MCMV-infected IFN- / R /  (bold line) versus
IFN- / R /  (gray histogram) mice. (B) In vitro activa-
tion of antigen-specific proliferation of CD8 T cells by
CD11b  ( ,  ) and CD11b  ( ,  ) DC subsets isolated
from d1.5 MCMV-infected IFN- / R /  (plain line)
versus IFN- / R /  (dotted line) mice. Bar graphs show
IFN-  production by the CD8 T cells under the same cul-
ture conditions. Experiments were performed as described
in the legend of Fig. 3 B.T
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itive feedback loop for production of the cytokines in vivo
during viral infections. Indeed, IFN- /  functions were
required for accumulation of PDCs in the spleen at the
time of local peak production of innate cytokines. Thus,
one of the mechanisms by which IFN- /  enhance their
own production during MCMV infection is the promotion
of PDC accumulation.
Both in mice and in humans, in vitro studies have dem-
onstrated that DCs can activate NK cells through mem-
brane contacts and that this may be at least partially inde-
pendent of IFN- /  and IL-12 production (for a review,
see reference 3). DCs have also been shown to activate
NK-dependent antitumoral responses in vivo (49). How-
ever, the roles of the different DC subsets for this function
have not been reported. Here, only DCs isolated from
d1.5 MCMV-infected mice were able to activate NK cy-
totoxicity and IFN-  production in 24 h of coculture,
and this function segregated with PDCs. Preliminary re-
sults suggested that IFN- /  functions and IL-12 produc-
tion were required for optimization of NK cell responses.
Whether other cytokines or cell–cell contacts are in-
volved still needs to be investigated. Whatever the case,
these results demonstrate that PDCs are more efficient
than other DC subsets at activating NK cells early during
MCMV infection.
In consistency with the observations reported in vitro
with resting human PDCs (48, 50), mouse PDCs isolated
from uninfected mice were relatively poor at antigen pre-
sentation. Responses to MCMV infection induced PDCs
to become very potent antigen-presenting cells for priming
CD8 T cells in vitro, with induction of higher levels of
IFN-  production than other DCs. In vivo, expression of
MCMV antigens seemed largely restricted to CD8   DCs.
These cells have also been shown to have the unique ability
to cross-present exogenous antigen in association with
MHC class I (11–13). Therefore, CD8   but not CD11b 
or PDCs are likely to play a major role in the direct activa-
tion of MCMV-specific CD8 T cells in vivo. However,
PDCs may be necessary for optimal induction of CD8 T
cell responses during MCMV infection, through IL-12 or
IFN- / –mediated effects on the T lymphocytes them-
selves or on other DC subsets. Indeed, it is shown here that
IFN- /  functions are required for CD8   DC matura-
tion in vivo during MCMV infection, and we have previ-
Figure 7. Model for DC subset functional specialization
and cross-talk in vivo during MCMV infection. See Dis-
cussion for Figure comments.T
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ously reported that IFN- /  promote CD8 T cell IFN- 
production in vivo during viral infections (33, 51, 52).
Altogether, the results presented here suggest a model of
DC subset specialization and DC cross-talk during MCMV
infection, with a central role for IFN- /  functions in reg-
ulating both innate and acquired immune responses (Fig. 7).
Early in response to MCMV challenge, PDCs are activated
to produce IFN- / . The cytokines can elicit mechanisms
directly mediating antiviral effects (arrow 1). They have also
a number of important immunoregulatory functions. In
particular, they induce NK cell cytotoxicity (arrow 2). Si-
multaneous PDC production of IL-12 is inducing NK cell
IFN-  responses. The PDC-derived IFN- /  is also con-
trolling the accumulation, maturation and cytokine produc-
tion of DC subsets. IFN- /  promote increased propor-
tions of PDCs in the spleen, and this is likely to contribute
to the amplification loop for secretion of the cytokines (ar-
row 3). PDC-produced IFN- /  are also generally re-
quired for maturation of DCs, especially the CD8   subset
(arrow 4). As this subset harbor viral products, it is likely to
initiate acquired CD8 T cell responses by presentation of
MCMV-derived epitopes in association with the MHC
class I molecules. Thus, IFN- /  induction of DC matura-
tion may indirectly contribute to the activation of CD8 T
cells. In addition, IFN- /  are enhancing the maturation
of, and inhibiting IL-12 production by, CD11b  DCs (ar-
row 5). Because CD11b  DCs have been reported particu-
larly efficient for priming CD4 T cells in other systems (12),
IFN- / –mediated regulation of this DC subset may be in
place to shape CD4 T cell responses during viral challenges.
Moreover, PDCs can participate in the activation of anti-
MCMV CD8 T cell responses through mechanisms in ad-
dition to those downstream of IFN- / –induced CD8  
DC maturation (arrow 6). In particular, if armed with anti-
gen, they may directly support antigen-specific activation of
the CD8 T cells. In addition, their production of cytokines
may enhance IFN-  production by CD8 T cells. Hence,
during MCMV infection in vivo, PDCs are specialized in
the activation of innate immune responses but, as a result of
their maturation and production of IFN- / , they may
also play a central role in the orchestration of global DC
functions and downstream adaptive immune responses.
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